Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study

Abstract

Background:

Several magnetic resonance imaging (MRI) studies investigated the evolution of multiple sclerosis (MS) lesions to understand the pathophysiological mechanisms leading to blood-brain barrier breakdown and lesion formation. Only a few assessed the early natural history of MS lesions using short-interval longitudinal MRI.

Objective:

The purpose of this study was to characterize MS lesion occurrence and early evolution on high-resolution MRI acquired at weekly intervals.

Methods:

Active lesions were characterized on 3D fluid attenuation inversion recovery (FLAIR) and gadolinium-enhanced 3D T1-weighted MRI performed weekly (seven weeks) on five untreated patients with relapsing–remitting MS (RRMS).

Results:

Active lesions (n=212) were detected in all patients. All showed contrast-enhancement on at least one time-point. Most new lesions (83.5%) were visible on FLAIR and post-contrast T1-weighted images at first detection; 11.2% showed activity on FLAIR images, one or more weeks before the appearance of contrast-enhancement; 12.5% enhanced before being apparent on FLAIR.

Conclusion:

Blood brain barrier disruption is a constant step in the natural history of active MS lesions, but does not always constitute the initial event. These findings are consistent with the existence of a subpopulation of lesions with an ‘inside-out’ genesis, where neurodegenerative processes might precede microglial activation, and a subsequent adaptive immune response.

Keywords

Magnetic resonance imaging multiple sclerosis relapsing–remitting T2 lesions

Get full access to this article

View all access options for this article.

References

Brück

Bitsch

Kolenda

. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783–793.

Katz

Taubenberger

Cannella

. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661–669.

Grossman

Gonzalez-Scarano

Atlas

. Multiple sclerosis: Gadolinium enhancement in MR imaging. Radiology 1986; 161: 721–725.

Bastianello

Pozzilli

Bernardi

. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 1990; 40: 591–595.

Kermode

Thompson

Tofts

. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 1990; 113: 1477–1489.

Miller

Rudge

Johnson

. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988; 111: 927–939.

Harris

Frank

Patronas

. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history. Ann Neurol 1991; 29: 548–555.

Thompson

Kermode

Wicks

. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991; 29: 53–62.

Barkhof

Scheltens

Frequin

. Relapsing-remitting multiple sclerosis: Sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992; 159: 1041–1047.

10.

Lai

Hodgson

Gawne-Cain

. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 339–341.

11.

Cotton

Weiner

Jolesz

. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 2003; 60: 640–646.

12.

Polman

Reingold

Banwell

. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302.

13.

Kurtkoti

Snow

Hiremagalur

. Gadolinium and nephrogenic systemic fibrosis: Association or causation. Nephrology 2008; 13: 235–241.

14.

Mattes

Haynor

Vesselle

. Nonrigid multimodality image registration. In: Sonka

Hanson

, eds Medical Imaging 2001: Image Processing. Proceedings of the International Society for Optics and Photonics (SPIE), San Diego, CA, 3 July 2001, pp.1609–1620. http://proceedings.spiedigitallibrary.org/proceeding.aspx?articleid=906829.

15.

Lewis

Fox

. Correction of differential intensity inhomogeneity in longitudinal MR images. Neuroimage 2004; 23: 75–83.

16.

Vemuri

Chen

. Image registration via level-set motion: Applications to atlas-based segmentation. Med Image Anal 2003; 7: 1–20.

17.

Calmon

Roberts

Eldridge

. Automatic quantification of changes in the volume of brain structures. In: Wells

Colchester

Delp

(eds) Medical image computing and computer-assisted interventation – MICCAI 1998. Proceedings of the Medical Image Computing and Computer Assisted Intervention Society (MICCAI), Cambridge, MA, 11–13 October 1998, pp.761–769. Berlin/Heidelberg: Springer-Verlag.

18.

Lucchinetti

Brück

Parisi

. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707–717.

19.

Filippi

Rocca

Martino

. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998; 43: 809–814.

20.

Werring

Brassat

Droogan

. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: A serial diffusion MRI study. Brain 2000; 123: 1667–1676.

21.

De Groot

Bergers

Kamphorst

. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions. Brain 2001; 124: 1635–1645.

22.

Marik

Felts

Bauer

. Lesion genesis in a subset of patients with multiple sclerosis: A role for innate immunity? Brain 2007; 130: 2800–2815.

23.

Henderson

APD

Barnett

Parratt

JDE

. Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Ann Neurol 2009; 66: 739–753.

24.

Seewann

Vrenken

van der Valk

. Diffusely abnormal white matter in chronic multiple sclerosis: Imaging and histopathologic analysis. Arch Neurol 2009; 66: 601–609.

25.

Soon

Tozer

Altmann

. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: A study of disease and lesion subtypes. Mult Scler 2007; 13: 884–894.